Home / Stocks / KYKOF

Kyowa Kirin Co. (KYKOF, Drugmakers) Stock Valuation & Fair Value

Mixed on our tests

Kyowa Kirin Co. (KYKOF, Drugmakers) trades at a current P/E of 16.2, about 38% below its historical normal valuation, with a forward growth estimate of 6.0% and a PEG of 2.69. Analysts' one-year estimates have been hit 45% of the time. Priced at its historical normal P/E of 26.3 on the same blended earnings, the 2026-11-06 close of $15.51 corresponds to about $25.20 a share. This is a valuation reference, not a price target.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

DATA AS OF 2026-11-07
Current P/E
16.2
Normal P/E
26.3
PEG
2.69
Fwd growth
6.0%
Div yield
2.9%
RSI (14)
52.1
Neutral
Technical context
  • Price $15.51 at the Nov 6 close, 1.2% above the 20-day average ($15.33) and 2.9% above the 50-day ($15.07).
  • RSI (14) at 52.1.
  • 52-week range $12.42 to $18.00: the price is 13.8% below the high and 24.9% above the low.

Valuation flags

Verdict history

tickerseer's rating changed 2 times after 2026-09-19 and is back where it started: mixed on our tests as of 2026-11-02.

Current P/E and rating by weekCurrent P/E moved from 15.3 to 17.8 between 2026-09-18 and 2026-10-30, against a normal P/E of 26.3, with 2 rating changes over 7 recorded weeks.2026-09-18: P/E 15.3, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 15.3, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 15.5, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 15.5, Mixed on our tests, recorded live 2026-09-282026-10-02: P/E 15.1, Favorable on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 15.1, Favorable on our tests, recorded live 2026-10-052026-10-09: P/E 14.9, Favorable on our tests, recalculated for the week of 2026-10-102026-10-09: P/E 14.9, Favorable on our tests, recorded live 2026-10-122026-10-16: P/E 17.3, Mixed on our tests, recalculated for the week of 2026-10-172026-10-16: P/E 17.3, Mixed on our tests, recorded live 2026-10-192026-10-23: P/E 16.6, Mixed on our tests, recalculated for the week of 2026-10-242026-10-23: P/E 16.6, Mixed on our tests, recorded live 2026-10-262026-10-30: P/E 17.8, Mixed on our tests, recalculated for the week of 2026-10-312026-10-30: P/E 17.8, Mixed on our tests, recorded live 2026-11-0215.020.025.0Sep 18Sep 28Oct 9Oct 20Oct 30Normal P/E 26.3
Favorable on our testsMixed on our tests

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 15.3-42%Mixed on our tests (recalculated)
2026-10-03P/E 15.1-43%Favorable on our tests (recalculated)
2026-10-10P/E 14.9-43%Favorable on our tests (recalculated)
2026-10-17P/E 17.3-34%Mixed on our tests (recalculated)
2026-10-31P/E 17.8-32%Mixed on our tests (recalculated)
2026-11-02P/E 17.8-32%Mixed on our tests ← now
Show all 14 readings
WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 15.3-42%Mixed on our tests (recalculated)
2026-09-21P/E 15.3-42%Mixed on our tests
2026-09-26P/E 15.5-41%Mixed on our tests (recalculated)
2026-09-28P/E 15.5-41%Mixed on our tests
2026-10-03P/E 15.1-43%Favorable on our tests (recalculated)
2026-10-05P/E 15.1-43%Favorable on our tests
2026-10-10P/E 14.9-43%Favorable on our tests (recalculated)
2026-10-12P/E 14.9-43%Favorable on our tests
2026-10-17P/E 17.3-34%Mixed on our tests (recalculated)
2026-10-19P/E 17.3-34%Mixed on our tests
2026-10-24P/E 16.6-37%Mixed on our tests (recalculated)
2026-10-26P/E 16.6-37%Mixed on our tests
2026-10-31P/E 17.8-32%Mixed on our tests (recalculated)
2026-11-02P/E 17.8-32%Mixed on our tests ← now

Frequently asked questions

Is Kyowa Kirin Co. stock overvalued?

At a current P/E of 16.2 versus its historical normal P/E of 26.3, Kyowa Kirin Co. trades about 38% below its typical valuation, with a PEG of 2.69 on 6.0% forward growth. tickerseer currently rates it mixed on our tests.

What is Kyowa Kirin Co.'s fair value and PEG?

Kyowa Kirin Co. trades at a current P/E of 16.2 against a historical normal P/E of 26.3, a PEG of 2.69, and a forward growth estimate of 6.0%. Priced at its historical normal P/E of 26.3 on the same blended earnings, the 2026-11-06 close of $15.51 corresponds to about $25.20 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Kyowa Kirin Co. changed?

tickerseer's rating changed 2 times after 2026-09-19 and is back where it started: mixed on our tests as of 2026-11-02.

Industry: Drugmakers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track KYKOF free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.